We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Allstate
ALL
$67.6B
| $37.6M | 0.09% |
296,419
+3,400
| +1% | +$445K |
|
252
Rockwell Automation
ROK
$49.6B
| $37.4M | 0.09% |
187,481
+31,800
| +20% | +$7.18M |
|
253
Agilent Technologies
A
$39.3B
| $37.1M | 0.09% |
312,594
-1,100
| -0.4% | -$135K |
|
254
Colgate-Palmolive
CL
$73.8B
| $37M | 0.08% |
461,720
-641,983
| -58% | -$50.2M |
|
255
Steris
STE
$22.7B
| $37M | 0.08% |
179,286
+74,700
| +71% | +$16.8M |
|
256
O'Reilly Automotive
ORLY
$74.9B
| $36.9M | 0.08% |
876,000
+120,000
| +16% | +$5.16M |
|
257
AutoZone
AZO
$49.4B
| $36.4M | 0.08% |
16,940
-2,300
| -12% | -$4.73M |
|
258
SBA Communications
SBAC
$20B
| $35.9M | 0.08% |
112,300
-1,300
| -1% | -$438K |
|
259
Kraft Heinz
KHC
$31.6B
| $35.6M | 0.08% |
934,332
+193,000
| +26% | +$7.73M |
|
260
Electronic Arts
EA
$53B
| $35.6M | 0.08% |
292,866
-800
| -0.3% | -$102K |
|
261
Global Payments
GPN
$24.1B
| $35.3M | 0.08% |
319,460
-31,200
| -9% | -$3.95M |
|
262
Evergy
EVRG
$19.3B
| $35.2M | 0.08% |
538,982
+299,500
| +125% | +$20.3M |
|
263
Cirrus Logic
CRUS
$6.74B
| $35.1M | 0.08% |
484,396
-40,604
| -8% | -$3.15M |
|
264
Consolidated Edison
ED
$39.9B
| $35.1M | 0.08% |
368,944
-500
| -0.1% | -$47.6K |
|
265
MSCI
MSCI
$41.6B
| $34.8M | 0.08% |
84,500
-400
| -0.5% | -$174K |
|
|
KRTX
266
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $34.8M | 0.08% |
275,000
-125,000
| -31% | -$14.4M |
|
267
Valero Energy
VLO
$88.9B
| $34.5M | 0.08% |
+325,000
| New | +$38.5M |
|
268
AstraZeneca
AZN
$241B
| $34.5M | 0.08% |
260,980
-94,020
| -26% | -$12.3M |
|
269
Patria Investments
PAX
$1.84B
| $34.4M | 0.08% |
2,599,244
-53,113
| -2% | -$838K |
|
270
Noble Corp
NE
$6.52B
| $34.1M | 0.08% |
1,346,905
-170,549
| -11% | -$5.61M |
|
271
Vulcan Materials
VMC
$36.9B
| $33.9M | 0.08% |
238,398
-200
| -0.1% | -$33K |
|
272
GCM Grosvenor
GCMG
$817M
| $33.9M | 0.08% |
4,942,786
| – | – |
|
273
Yum! Brands
YUM
$40.3B
| $33.7M | 0.08% |
297,002
+70,200
| +31% | +$8.16M |
|
274
Southwest Gas
SWX
$6.44B
| $33.5M | 0.08% |
385,000
+285,000
| +285% | +$25.2M |
|
275
Idacorp
IDA
$8.36B
| $33.1M | 0.08% |
312,500
+37,500
| +14% | +$4.05M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.